Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

5 tips for a smoother Christmas and New Year's journey

In the run-up to and during the Christmas and New Year holidays, we will see an increased number of passengers as more people want to fly. Are you planning to travel from one of Swedavia's ten airports? For example, Arlanda, Bromma or Landvetter? Here are 5 tips to make sure you get your journey off on the right foot. · For all airports, you should plan to arrive at the airport when your check-in or bag drop opens. For Stockholm Arlanda, there is a service where you can search for your flight and you will get a recommended time to arrive at the airport based on your particular flight.

Bedroom Lighting Ideas to Create The Perfect Ambience

Getting your bedroom lighting right is key to creating a relaxing retreat. Your bedroom should be a place where you can relax and unwind at the end of the day. It's important to set the scene and create the right mood to achieve this. Layering your lighting in the bedroom is the perfect way to create a soft and welcoming ambience.   [Blur image of a blurry background Description automatically generated]   Lighting not only helps to set the scene in the room, but it can also act as a decorative element. If you choose the wrong type of lighting in the bedroom, it can make the

B2B Marketing Blueprint Launch Announcement from Snitcher

Hilversum, Netherlands - Technology company standout Snitcher, introduces the groundbreaking B2B Marketing Blueprint, precisely crafted resource aimed at driving business expansion synergistically with visitor identification.Every element within the set, such as the Buyer Persona Model, Content Strategy, and Social Media, encapsulates essential marketing strategies and proven best practices derived from prominent industry literature, translated into practical and actionable steps. "At Snitcher, we understand that the heart of effective B2B marketing lies in truly knowing your audience.

STOREBRAND ASA: Ministry of Finance subpoenas Tax Appeals Committee

The Ministry of Finance has today issued a subpoena against the Tax Appeals Committe (Skatteklagenemda) in the tax case concerning whether group contributions should reduce the tax value of shares. The Tax Appeals board gave a judgement that provided full support for Storebrand Livsforsikring AS view in the case in point. Reference is made to the stock exchange announcement dated 20 June 2023 for additional information.  There is no new information in the subpoena which, in Storebrand Livsforsikring AS' opinion, provides grounds for changes in the company's accounts.  Lysaker, 13

STOREBRAND LIVSFORSIKRING AS: Ministry of Finance subpoenas Tax Appeals Committee

Ministry of Finance has today issued a subpoena against the Tax Appeals Committe (Skatteklagenemda) in the tax case concerning whether group contributions should reduce the tax value of shares. The Tax Appeals board gave a judgement that provided full support for Storebrand Livsforsikring AS view in the case in point. Reference is made to the stock exchange announcement dated 20 June 2023 for additional information.  There is no new information in the subpoena which, in Storebrand Livsforsikring AS' opinion, provides grounds for changes in the company's accounts.  Lysaker, 13 December

Nordea Bank Abp: Repurchase of own shares on 13.12.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares13.12.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 13.12.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |49,578 |10.80 |535,338.29

Chief Financial Officer Michael Ladurner to leave Intrum

Intrum AB (publ) has come to an agreement with Michael Ladurner, Chief Financial Officer (CFO), regarding his departure from the company.Anders Blomqvist has been appointed interim CFO with immediate effect, and Michael Ladurner will support the organisation to ensure a smooth CFO handover through the first quarter of 2024.“Michael has played an important role for Intrum during the last seven years. Joining as an investment professional, Michael was internally recruited to the CFO position 2021, with the mission to establish a solid financial structure and governance processes. Given the

Navamedic and Orion Corporation sign non-binding term sheet for Flexilev® in Europe

Oslo, 13. December 2023 - Navamedic ASA and Orion Corporation (“Orion”) have today signed a non-binding term sheet for a licensing- and supply agreement for Flexilev®, including the Orafid dispenser, across Europe, not including Sweden, Norway, Denmark, and Iceland, where Navamedic will market and sell the product. Flexilev® is a novel prescription treatment for Parkinson’s disease and was added to Navamedic’s product portfolio following the acquisition of Sensidose AB in May 2023.Orion and Navamedic have agreed to enter into a final agreement by the end of the first quarter of 2024. “

Saudi Electricity Company Accelerates its Sustainability Journey in the Kingdom using Digital & AI

Riyadh; Dec 2023: Saudi Electricity Company (SEC) has taken a significant step in its sustainability journey by signing a Memorandum of Understanding (MoU) with Net-Zero Technology Center (NZTC) and Accenture. The agreement aims to leverage digital and AI technologies to promote low-carbon solutions in the Kingdom and beyond.Together they will develop and launch a Sustainability Center of Excellence, to drive growth of low-carbon solutions and enable SEC’s Net-Zero targets by stimulating national innovation and entrepreneurship while upskilling the local workforce.  "Today marks a

Curasight A/S appoints CRO to run Phase 2 study with uTRACE[®] in prostate cancer

· Phase 2 study is part of the collaboration between Curasight and Curium announced earlier this year · Appointment of clinical CRO marks further step in progress in development of uTRACE as a potential new diagnostic solution for prostate cancer Copenhagen, December 13, 2023 - Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) today announced it has signed an agreement with ABX-CRO, an experienced international clinical research organization serving the pharmaceutical industry, to run the phase 2 study investigating uTRACE[®] in improving the diagnosis of prostate cancer.

STENOCARE: The deadline for trading TO1 Warrants is Dec 15

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (Stenocare) is currently offering new shares at a discounted rate of DKK 2.11 for TO1 Warrant owners and, through the acquisition of Warrants, new investors. The deadline for trading TO1 Warrants is end of business day December 15Deadline for trading TO1 Warrants: The important deadline for trading is December 15 at 16:59 (CET). Warrant owners who are not planning to exercise their TO1 Warrants have the opportunity to sell the warrants before the deadline. Investors that are interested in subscribing

NPRO: Equity issue NOK 500 million as part of the financing of the Telegrafen acquisition

The general meeting of Norwegian Property ASA has today resolved to increase the company's equity with NOK 500 million. The new share capital is subscribed by the company's sole shareholder, Geveran Trading Co. Limited. The issue is part of the refinancing of the existing bonds to Telegrafen Holding AS which was acquired in November.   Minutes of the extraordinary general meeting and updated articles of association are attached.

#23-390 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Quickbit eu AB (publ) adopts dividend policy

On 22 May 2023, the Extraordinary General Meeting in Quickbit eu AB (publ) ("Quickbit") resolved to instruct the Board of Directors to adopt a dividend policy for Quickbit. The Board of Directors of Quickbit has today, 13 December 2023, resolved to adopt the following dividend policy.· The board of directors' top priority is to ensure that Quickbit has a financial position strong enough to support both organic growth and selective acquisitions. In addition, Quickbit wants to maintain a strong balance sheet. The payment of capital to the shareholders must be adapted to profit development and

#23-389 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

OncoZenge Announces Advisory Board with Dr Stephen Sonis and Dr Pooja Nandwani Patel

Stockholm, Sweden, December 13th 2023 – OncoZenge AB (publ) (Nasdaq First North Growth Market: ONCOZ), a leading biotechnology company developing BupiZenge™, an innovative therapy for treating oral pain, today announces the formation of an Advisory Board of renowned scientists and clinicians with expertise in oral medicine and cancer.The Advisory Board will provide strategic guidance and consultation to OncoZenge as it advances its research and development, with a focus on advancing BupiZenge™ through phase III studies and eventual market approval. The board's members bring a wealth of

Zwipe AS – preliminary results of the rights issue

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO BUY SECURITIES IN ZWIPE AS. SEE ALSO THE SECTION "IMPORTANT INFORMATION" BELOW IN THIS DOCUMENT. OSLO, NORWAY – 13 DECEMBER 2023 – Reference is made to the stock exchange announcement published by Zwipe AS (the "Company") on 28 November 2023,

Director/PDMR Shareholding

12 December 2023 Redde Northgate plc (“Redde Northgate” or the “Company”) Director/PDMR Shareholding TRANSFER OF SHARES On 12 December 2023 Mark Butcher, a Non-Executive Director of the Company, transferred 5,400 ordinary shares in the Company between two share accounts in which he is the sole beneficial owner. No change to the number of shares beneficially held by the Director has occurred in connection with the transfer, and following the transfer the Director remains interested in 34,676 ordinary shares. The transfer was effected through the sale of 5,400 ordinary shares

Hamlet BioPharma Announces the Nomination of Elisabeth Parker to its Board of Directors

Hamlet BioPharma, the innovative pharmaceutical company currently advancing several phase II trials targeting infectious diseases and cancer, along with an extensive project and patent portfolio, is delighted to announce the nomination of Dr. Elisabeth Parker to its Board of Directors. Dr. Parker's nomination will bring business development, international pharmaceutical industry networks and leadership excellence to the company and strengthen the continued growth of Hamlet BioPharma. Dr. Elisabeth Parker is currently serving as a Senior Investment Advisor for Healthcare and Life Sciences

Teesside University secures funding for groundbreaking research in waste-to-energy

Two Teesside University academics have received funding for groundbreaking research investigating how to reduce the carbon footprint from waste-to-energy plants.Professor Dawid Hanak, in collaboration with Professor Kumar Patchigolla, has been granted funding from the UK Carbon Capture and Storage Research Community’s (UKCCSRC) Flexible Funding call to look at how carbon capture technology can be used alongside waste-to-energy (WtE) plants. [Professor Dawid Hanak] The research will address a critical need for the East Coast Cluster by assessing the techno-economic and carbon footprint

There are no items matching the current filter
There are no more items matching the current filter
Back to top